Millennium Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.29M Sell
24,900
-7,100
-22% -$2.33M ﹤0.01% 2522
2025
Q4
$11.2M Buy
32,000
+14,600
+84% +$4.93M ﹤0.01% 2140
2025
Q3
$5.62M Sell
17,400
-20,000
-53% -$6.22M ﹤0.01% 3019
2025
Q2
$14.5M Sell
37,400
-81,500
-69% -$32.8M 0.01% 1890
2025
Q1
$51.7M Buy
118,900
+101,200
+572% +$40.6M 0.03% 749
2024
Q4
$6.53M Sell
17,700
-26,000
-59% -$10.9M ﹤0.01% 2583
2024
Q3
$22.7M Sell
43,700
-23,400
-35% -$12.5M 0.01% 1436
2024
Q2
$36.4M Sell
67,100
-100
-0.1% -$52.9K 0.02% 1013
2024
Q1
$34.8M Sell
67,200
-53,700
-44% -$26.7M 0.01% 1075
2023
Q4
$57M Buy
120,900
+40,400
+50% +$18.7M 0.02% 715
2023
Q3
$35.1M Sell
80,500
-25,900
-24% -$11.7M 0.02% 959
2023
Q2
$47.3M Sell
106,400
-30,900
-23% -$14.3M 0.02% 773
2023
Q1
$63.1M Sell
137,300
-66,000
-32% -$31.4M 0.04% 565
2022
Q4
$104M Buy
203,300
+118,700
+140% +$60.3M 0.06% 360
2022
Q3
$38.4M Buy
84,600
+46,500
+122% +$22.2M 0.02% 843
2022
Q2
$18.4M Sell
38,100
-4,900
-11% -$2.42M 0.01% 1399
2022
Q1
$21.1M Sell
43,000
-39,300
-48% -$18M 0.01% 1337
2021
Q4
$38.1M Buy
82,300
+7,600
+10% +$3.2M 0.02% 905
2021
Q3
$27.8M Buy
74,700
+45,300
+154% +$17.2M 0.02% 1033
2021
Q2
$11.2M Buy
29,400
+26,600
+950% +$10.2M 0.01% 1754
2021
Q1
$1M Sell
2,800
-9,200
-77% -$2.96M ﹤0.01% 4215
2020
Q4
$3.85M Sell
12,000
-3,000
-20% -$921K ﹤0.01% 2701
2020
Q3
$4.03K Buy
15,000
+13,100
+689% +$3.52M 0.01% 2037
2020
Q2
$500K Buy
+1,900
New +$507K ﹤0.01% 3402
2020
Q1
Sell
-1,600
Closed -$483K 4011
2019
Q4
$483K Buy
+1,600
New +$440K ﹤0.01% 3401
2019
Q2
Sell
-3,000
Closed -$861K 4140
2019
Q1
$861K Buy
+3,000
New +$868K ﹤0.01% 2954

Other funds holding ELV

Millennium Management's ELV Position: Q1 2026 in Review

Millennium Management increased its Elevance Health (ELV) stake by 103% in Q1 2026, buying an estimated $153M and bringing the position to 919,171 shares worth $269M. The position accounts for 0.11% of the portfolio, ranked #154.

Millennium Management first reported a position in ELV in Q2 2013 and has held it in 49 quarters since. The position peaked at $431M in Q3 2023. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Millennium Management held 919,171 shares of Elevance Health worth $269M as of Q1 2026.
  • Millennium Management bought 466,051 Elevance Health shares in Q1 2026, an estimated $153M.
  • Elevance Health made up 0.11% of Millennium Management's portfolio in Q1 2026, its #154 holding.
  • Millennium Management first reported a position in Elevance Health in Q2 2013 and has held it in 49 quarters since.
  • Millennium Management's Elevance Health position peaked at $431M in Q3 2023.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.